The global biopharmaceutical excipients market has seen significant growth in recent years, with a valued size of USD 2.45 billion in 2022. Projected to grow at a CAGR of 5.50% from 2023 to 2030, this industry is expected to continue its upward trajectory. The driving forces behind this growth include increased investments in R&D for biosimilars and the patent expiration of top-selling biologics.

Key Companies & Market Share Insights

Industry leaders are investing heavily in strategic collaborations, acquisitions, mergers, and agreements to bolster their product portfolios and gain a competitive edge in the market. To maintain their market position, companies are also focusing on securing product approvals and expanding their geographic presence. For example, Evonik Industries AG recently commenced construction of a new facility in Indiana, US, aimed at securing global supplies of functional excipients for RNA medicines and driving growth in the biopharmaceutical excipients sector. Key players in this space include

• Merck KGaA

• Colorcon

• BASF SE

• Associated British Foods plc

• Signet Excipients Pvt. Ltd (IMCD)

• Sigachi Industries Limited

• Spectrum Chemical Manufacturing Corp.

• Roquette Frères

• IMCD

• Clariant

• DFE Pharma

• J. RETTENMAIER & SÖHNE GmbH + Co KG

• Evonik Industries AG

Product Insights

The pharmaceutical industry has traditionally relied on carbohydrate-based excipients, such as starch, sucrose, and dextrose, to formulate drugs. This market trend accounted for 35.81% of the total revenue in 2022 and is projected to remain a leading segment throughout the forecast period. The widespread adoption of these excipients can be attributed to their versatility and compatibility with various drug delivery systems, making them an integral component in many formulations.

Regional Insights

In 2022, North America dominated the market with a significant share of 31.85%, largely due to the presence of prominent pharmaceutical manufacturing companies in the region. The demand for biopharmaceutical production has been substantial here, driven by the need for high-quality raw materials and regulatory compliance. As a result, regional excipient manufacturers have prioritized scaling up their production capabilities using biopharmaceutical excipients that meet stringent standards, thereby meeting this growing demand.

Global Biopharmaceutical Excipients Market Report Segmentation

This comprehensive analysis forecasts revenue and volume growth across the globe, as well as at the regional and national levels, spanning from 2018 to 2030. The report delves into the latest industry trends for each sub-segment, offering in-depth insights into the evolving landscape of biopharmaceutical excipients. With a focus on market segmentation by product and region, this study provides a nuanced understanding of the market's growth prospects and emerging opportunities.

Get Free Sample Copy - https://www.theresearchinsights.com/reports/biopharmaceutical-excipients-market-521/request-sample

About Us:

The Research Insights is a global leader in data analytics and a fundamental tool to answer questions and acquire knowledge regarding the complexity of interactions between the internal and external factors affecting the dynamics of a marketplace. We exemplify innovative, descriptive, and comprehensive revelations through market research to satisfy your individual and organizational objectives. We assist you to make well-informed, profound and favorable decisions to encompass the advantages of upcoming trends, progressions, estimations, and opportunities through our precise understanding of the market.

Contact Us:

The Research Insights Pvt. Ltd.

[email protected]

+1-312-313-8080